ETTX Annual SG&A
$15.21 M
+$2.00 M+15.16%
31 December 2021
Summary:
As of February 5, 2025, ETTX annual selling, general & administrative expenses is $15.21 million, with the most recent change of +$2.00 million (+15.16%) on December 31, 2021. During the last 3 years, it has risen by +$5.05 million (+49.71%).ETTX Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ETTX Quarterly SG&A
$4.94 M
+$662.00 K+15.49%
31 March 2022
Summary:
As of February 5, 2025, ETTX quarterly selling, general & administrative expenses is $4.94 million, with the most recent change of +$662.00 thousand (+15.49%) on March 31, 2022. Over the past year, it has increased by +$1.63 million (+49.26%).ETTX Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ETTX TTM SG&A
-$905.22 M
-$51.70 M-6.06%
31 March 2022
Summary:
As of February 5, 2025, ETTX TTM selling, general & administrative expenses is -$905.22 million, with the most recent change of -$51.70 million (-6.06%) on March 31, 2022. Over the past year, it has dropped by -$917.95 million (-7208.10%).ETTX TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ETTX Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +15.2% | +49.3% | -7208.1% |
| 3 y3 years | +49.7% | +54.8% | -6673.4% |
| 5 y5 years | +171.7% | +266.7% | -6673.4% |
ETTX Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | at high | at high | -5475.1% |
Entasis Therapeutics Holdings Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $4.94 M(+15.5%) | $16.84 M(+10.7%) |
| Dec 2021 | $15.21 M(+15.2%) | $4.27 M(-1.1%) | $15.21 M(+9.3%) |
| Sept 2021 | - | $4.32 M(+30.5%) | $13.91 M(+8.6%) |
| June 2021 | - | $3.31 M(+0.1%) | $12.80 M(+0.5%) |
| Mar 2021 | - | $3.31 M(+11.2%) | $12.73 M(-3.6%) |
| Dec 2020 | $13.21 M(-4.1%) | $2.97 M(-7.4%) | $13.21 M(-4.8%) |
| Sept 2020 | - | $3.21 M(-0.9%) | $13.87 M(-2.2%) |
| June 2020 | - | $3.24 M(-14.3%) | $14.18 M(-1.3%) |
| Mar 2020 | - | $3.78 M(+3.8%) | $14.36 M(+4.3%) |
| Dec 2019 | $13.77 M | $3.64 M(+3.4%) | $13.77 M(+10.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2019 | - | $3.52 M(+2.9%) | $12.45 M(+13.1%) |
| June 2019 | - | $3.42 M(+7.3%) | $11.01 M(+8.6%) |
| Mar 2019 | - | $3.19 M(+37.4%) | $10.13 M(-0.3%) |
| Dec 2018 | $10.16 M(+81.5%) | $2.32 M(+11.9%) | $10.16 M(+1.7%) |
| Sept 2018 | - | $2.08 M(-18.6%) | $9.99 M(+7.9%) |
| June 2018 | - | $2.55 M(-20.8%) | $9.26 M(+37.9%) |
| Mar 2018 | - | $3.22 M(+49.6%) | $6.71 M(+92.0%) |
| Dec 2017 | $5.60 M(+68.3%) | $2.15 M(+59.8%) | $3.50 M(+159.8%) |
| Sept 2017 | - | $1.35 M | $1.35 M |
| Dec 2016 | $3.33 M | - | - |
FAQ
- What is Entasis Therapeutics Holdings annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Entasis Therapeutics Holdings?
- What is Entasis Therapeutics Holdings annual SG&A year-on-year change?
- What is Entasis Therapeutics Holdings quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Entasis Therapeutics Holdings?
- What is Entasis Therapeutics Holdings quarterly SG&A year-on-year change?
- What is Entasis Therapeutics Holdings TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Entasis Therapeutics Holdings?
- What is Entasis Therapeutics Holdings TTM SG&A year-on-year change?
What is Entasis Therapeutics Holdings annual selling, general & administrative expenses?
The current annual SG&A of ETTX is $15.21 M
What is the all time high annual SG&A for Entasis Therapeutics Holdings?
Entasis Therapeutics Holdings all-time high annual selling, general & administrative expenses is $15.21 M
What is Entasis Therapeutics Holdings annual SG&A year-on-year change?
Over the past year, ETTX annual selling, general & administrative expenses has changed by +$2.00 M (+15.16%)
What is Entasis Therapeutics Holdings quarterly selling, general & administrative expenses?
The current quarterly SG&A of ETTX is $4.94 M
What is the all time high quarterly SG&A for Entasis Therapeutics Holdings?
Entasis Therapeutics Holdings all-time high quarterly selling, general & administrative expenses is $4.94 M
What is Entasis Therapeutics Holdings quarterly SG&A year-on-year change?
Over the past year, ETTX quarterly selling, general & administrative expenses has changed by +$1.63 M (+49.26%)
What is Entasis Therapeutics Holdings TTM selling, general & administrative expenses?
The current TTM SG&A of ETTX is -$905.22 M
What is the all time high TTM SG&A for Entasis Therapeutics Holdings?
Entasis Therapeutics Holdings all-time high TTM selling, general & administrative expenses is $16.84 M
What is Entasis Therapeutics Holdings TTM SG&A year-on-year change?
Over the past year, ETTX TTM selling, general & administrative expenses has changed by -$917.95 M (-7208.10%)